How Can Stem Cells
Support Rheumatoid
Arthritis?

Regenerative Therapy Offers New Hope for Arthritis Patients

Rheumatoid arthritis (RA) is a chronic autoimmune disorder that causes severe joint pain, swelling, and inflammation. The condition can also affect other parts of the body, leading to fatigue, anemia, and even organ damage. Over time, joint stiffness can limit mobility and daily function, making it harder to enjoy an active lifestyle.

Stem cell therapy provides an opportunity to promote healing, reduce inflammation, and restore joint function.

See if stem cell treatment is right for you.

Advanced Stem Cell Therapy Available For:

• Arthritis
• Rheumatoid Arthritis
• Autoimmune diseases
• Joint pain
• Chronic inflammation
• Degenerative conditions

Transform Your Health with Advanced Stem Cell Therapy

Our medical and scientific teams continue to research and refine therapies for autoimmune diseases. Contact a ZignaGenix Patient Advocate to learn if regenerative therapy may offer new treatment options for your rheumatoid arthritis.

A Leader in Regenerative Therapy for Arthritis

At ZignaGenix, advanced stem cell therapy offers a potential solution for those struggling with chronic pain and inflammation caused by RA. Our therapies utilize the body’s natural healing processes to help:

• Reduce inflammation in joints
• Relieve pain and swelling
• Promote tissue regeneration
• Improve joint flexibility and mobility

New Treatment Options for Arthritis Relief

Stem cell therapy has helped many patients who felt there was no way forward. Regenerative therapy can reduce pain and improve mobility, restoring a more active lifestyle.

Scientific References and Research

  • Our team collaborates with leading scientists worldwide, ensuring that our treatments are based on the latest research. View published studies that support the efficacy of our treatment protocols.

Don’t Settle for Chronic Pain

Find out if stem cell therapy may help you reduce pain and improve mobility.

High-Potency
Stem Cell Treatment

ZignaGenix Hypoxic Cells and Exosomes

ZignaGenix Hypoxic Cellular Therapy is our signature regenerative program, utilizing high-potency mesenchymal stem cells (MSCs) derived from Wharton’s Jelly umbilical cord tissue. These cells are cultivated under controlled hypoxic (low-oxygen) conditions using proprietary laboratory protocols designed to enhance cellular resilience and biologic activity.Our advanced cellular platform integrates hypoxic MSCs and MSC-derived exosomes to support immune balance, reduce inflammatory signaling, and promote tissue repair pathways. These cells demonstrate:

Each cellular batch undergoes extensive screening and quality verification to ensure purity, potency, and viability prior to clinical application.